Human CD56+CD39+ dNK cells support fetal survival through controlling trophoblastic cell fate: immune mechanisms of recurrent early pregnancy loss

Wentong Jia,Liyang Ma,Xin Yu,Feiyang Wang,Qian Yang,Xiaoye Wang,Mengjie Fan,Yan Gu,Ran Meng,Jian Wang,Yuxia Li,Rong Li,Xuan Shao,Yan-Ling Wang
DOI: https://doi.org/10.1093/nsr/nwae142
IF: 20.6
2024-04-11
National Science Review
Abstract:Abstract Decidual natural killer (dNK) cells are the most abundant immune cells at early stage of pregnancy in rodents and humans, and emerging single-cell transcriptomic studies have uncovered various human dNK subsets that are disrupted in patients experiencing recurrent early pregnancy loss (RPL) at early gestational stage, suggesting a connection between abnormal proportions or characteristics of dNK subsets and RPL pathogenesis. However, the functional mechanisms underlying this association remain unclear. Here, we established a mouse model by adoptively transferring human dNK cells into pregnant NOG (NOD/Shi-scid/IL-2Rγnull) mice, where human dNK cells predominantly homed into the uteri of recipients. Using this model, we observed a strong correlation between the properties of human dNK cell and the outcomes of pregnancy. The transfer of dNK cells from RPL patients (dNK-RPL) remarkably worsened early pregnancy loss and impaired placental trophoblast cell differentiation in the recipients. These adverse effects were effectively reversed by transferring CD56+CD39+dNK cells. Mechanical studies revealed that CD56+CD39+ dNK subset facilitate early differentiation of mouse trophoblast stem cells (mTSCs) towards both invasive and syncytial pathways through secreting macrophage colony-stimulating factor (M-CSF). Administration of recombinant M-CSF to NOG mice transferred with dNK-RPL efficiently rescued the exacerbated pregnancy outcomes and fetal/placental development. Collectively, this study established a novel humanized mouse model featuring functional human dNK cells homing into the uteri of recipients and uncovered the pivotal role of M-CSF in fetal-supporting function of CD56+CD39+ dNK cells during early pregnancy, highlighting that M-CSF may be a previously unappreciated therapeutic target for intervening RPL.
multidisciplinary sciences
What problem does this paper attempt to address?
The problems that this paper attempts to solve are as follows: to explore how different subsets of human decidual natural killer cells (dNK cells) affect fetal survival and placental development during early pregnancy, especially to study the mechanism of action of CD56+CD39+ dNK cells in supporting fetal survival, and how these cells regulate the early differentiation pathways of trophoblast stem cells by secreting macrophage colony - stimulating factor (M - CSF). In addition, the paper also aims to reveal the association between abnormal dNK cell subset ratios or characteristics and the pathogenesis of recurrent early pregnancy loss (RPL), and to explore the possibility of M - CSF as a potential therapeutic target for intervening in RPL. By establishing a new humanized mouse model in which human dNK cells are transplanted into pregnant NOG mice, the paper observed the effects of human dNK cells from different sources on pregnancy outcomes, especially the role of CD56+CD39+ dNK cells. The study found that dNK cells isolated from women with normal pregnancy could significantly improve pregnancy outcomes, while dNK cells isolated from RPL patients led to increased early pregnancy loss and impaired placental trophoblast cell differentiation. Further research indicates that CD56+CD39+ dNK cells promote the early differentiation of mouse trophoblast stem cells towards invasive and syncytial pathways by secreting M - CSF, thereby supporting fetal growth and placental development. These findings not only clarify the functional mechanisms of human dNK cell subsets in maintaining pregnancy, but also provide new ideas for the treatment of RPL.